About us | Mezzion

About us

Delivering hope where there was none before

Our vision

Mezzion Pharmaceuticals continuously strives to discover, develop and deliver new hope in areas of medicine where there was none before. With our extensive experience in drug development and clinical trials, and our strong conviction and compassion for everything we do, we know that our vision of a future where no patient with a rare disease is without hope is firmly within our grasp.

Meet our Leadership Team

James L. Yeager, RPh, PhD

James L. Yeager, RPh, PhD

Dr. Yeager is an Executive Director at Mezzion Pharma Co. Ltd and has over 40 years of working in the pharmaceutical industry in research and management positions.

Dean Park, CEO

Dean Park, CEO

Mr. Park is the Founder of Mezzion Pharma Co. Ltd. and also serves as its Chief Executive Officer. Mr. Park also founded and served as Chief Executive Officer and/or President of a number of other successful international companies, including AIA Capital Korea, Far East Investment, Hutchison Corporate Access and Ricco Nine. Mr. Park has previously served as Vice President and Director of the investment banking group at Merrill Lynch Capital Markets.

Peter Manso

Peter Manso

Mr. Manso is an Executive Director at Mezzion Pharma Co. Ltd. and Mezzion Pharmaceuticals, Inc. Mr. Manso is also Senior Vice-President and General and Inteelectual Property Counsel of Mezzion with more than 40 years of experience in the areas of branded pharmaceutical patent law and lifecyle management.

Michael C. Vaia

Michael C. Vaia

Mr. Vaia is the Senior Vice President of IT and CIO at Mezzion Pharmaceuticals, Inc. Mr. Vaia has over 25 years of IT Leadership experience and has previously held roles in the Pharmaceutical industry at Abbott, AbbVie, Baxter, Hospira, and Shire.

Our Scientific Advisory Board

Dr. David Goldberg

  • Attending Cardiologist and Director of the Exercise Physiology Laboratory at Children’s Hospital of Philadelphia
  • MD at UMDNJ-Robert Wood Johnson Medical School

Dr. Jack Rychik

  • Director of the Fetal Heart Program and the Single Ventricle Survivorship Program at Children’s Hospital of Philadelphia
  • MD at State University of New York, Downstate Medical Center

Dr. Steven Paridon

  • Attending Cardiologist and Director of the Exercise Physiology Laboratory at Children’s Hospital of Philadelphia
  • MD at Case Western Reserve University School of Medicine

Dr. Bryan Goldstein

  • Associate Director at the Cardiac Catheterization Laboratory at Cincinnati Children’s Hospital Medical Center
  • MD at Boston University School of Medicine

YOU ARE NOW LEAVING THE SITE

Click continue to proceed